At the news
? BEARISHIMPACT 6/10 PRESS-RELEASE filed Nov 4, 2026 at 16:01 ET
Baird Medical received a Nasdaq deficiency notice for failing to maintain the minimum $1.00 bid price for 30 consecutive business days. The company has a 180-day compliance period until May 3, 2027, to regain compliance, and its shares continue to trade uninterrupted. With a market cap of only $6M, the delisting risk is material if the bid price is not cured.
- Nasdaq notified Baird Medical on November 2, 2026 of non-compliance with minimum $1.00 bid price rule (Listing Rule 5550(a)(2)).
- Company has 180 calendar days, until May 3, 2027, to regain compliance by having a closing bid price of $1.00 or above for 10 consecutive business days.
- If not cured, the company may be eligible for an additional 180-day grace period or face delisting.
- Market cap is approximately $6M, making delisting a potentially existential risk.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access